Join the PDA Advanced Therapy Medicinal Products Conference 2026, taking place on 25–26 June 2026 under the theme “Innovation without Borders: Managing Global Expectations in the Age of Intelligence.” The conference will bring together leading experts in cell and gene therapy to discuss key advances and challenges across the full ATMP lifecycle, from development to commercial manufacturing.

The program will highlight several core focus areas, including Aseptic Processing & Contamination Control, where you will gain insights into novel risk-based strategies to enhance airflow visualization studies and best practices for maintaining sterility in ATMP manufacturing environments. It will also address Lifecycle Risk Management, helping you navigate regulatory challenges for hybrid ATMPs and digital delivery systems, temperature excursion management, and the strategic timing for implementing GMP raw materials. In addition, Advanced Manufacturing Platforms will feature prominently, showcasing how platform processes and agile development tools are advancing rAAV manufacturing and how operationalization strategies for cell therapy development can be effectively implemented.

Through plenary sessions, focused presentations, interactive round tables, poster walks, and an exhibition, regulatory specialists, industry leaders, and scientists will share practical insights and future perspectives on building robust, innovative, and compliant ATMP operations. Networking breaks, a dedicated evening event, and guided poster activities will offer ample opportunities for exchange and collaboration across the global ATMP community.

This conference will be part of the PDA Innovative Therapies Summit 2026, alongside the PDA Virus Conference 2026, which will take place on 22-23 June 2026, at the same venue.

View the event here.